*** PLEASE NOTE THIS EVENT WILL BE HELD AT THE LANGHAM THIS YEAR ***

This event has reached capacity. Registration is now closed.

Please join us on Wednesday, January 23rd for what has proven to be the must-attend event of the year for policy makers, biotechnology, life sciences, healthcare and business leaders, and other key stakeholders - The 2013 MassBio Policy Leadership Breakfast.

AGENDA

Welcome:                  

• Geoff MacKay, Chairman, MassBio Board of Directors
• Robert K. Coughlin, President & CEO, MassBio                    

Keynote Speaker:     

• The Honorable Therese Murray (invited), President of the Massachusetts State Senate

Panel Discussion: Biosimilars: Implementing Sound Policies to Ensure Patient Safety

The introduction of biosimilar and interchangeable biologics into clinical practice will present some new challenges that have not historically been present with small molecule generic medicines. Current state rules on substitution will very likely need to be updated or completely re-written in the context of biosimilar and interchangeable biologic medicines.  Listen as an expert panel discusses what important factors should be considered when crafting sound public policy around biosimilars.

Moderator:     

• Robert K. Coughlin, President & CEO, MassBio

Panelists (invited):       

• David Charles, MD, Chief Medical Officer, Vanderbilt University Clinical Neurosciences Institute
• Professor William S. Hancock, Bradstreet Chair in Bioanalytical Chemistry, Barnett Institute of Chemical and Biological Analysis, Northeastern University
• Fritz Bittenbender, Vice President of Alliance Development/State Government Affairs, BIO
• Susan Nesci, Patient Advocate, Vice President Public Policy & Advocacy, Arthritis Foundation, New England Region

Don't miss this chance to have your voice be heard and network with a group of who's who in state and federal politics, healthcare and life sciences. If you would like to propose a question for a panelist or for panelists to address, please email it to policy@massbio.org.    

Thank you to our sponsors:

BIO, Pfizer, Cubist, Genentech, Sunovion, AT&T and Fisher